Profit of 66% crece Ouro Fino 3Q of 2015

The net profits of the Ouro Fino Animal health company with expertise in research, development, production and marketing of veterinary medicines, grew 66.7%, to R $ 19 million in 3Q of 2015, ended on 30 September. In the nine months consolidated for the year, the company registered a net profit of 45.4 million R$, 38.4% increase in front of same period in 2014. According to the company, the profit to September reflects the growth of the result of operations and financial results.
The company's net revenue grew 44% in the third quarter, to 149.5 million R$. In the nine months of the year, the growth was 24.4%, to R$ 369 million. The company's flagship, the medicines for farm animals, was primarily responsible for the increase, with a revenue growth of 41% in the quarter, to 120.3 million R$. In the nine months of the year, the revenue of this segment grew 25.2 percent to 300.5 million R$.
The earnings before interest, taxes, depreciation and amortization (Ebitda) rose 53%, adjusted for R$ 37.5 million in the third quarter, with a margin of 25.1%, 1.5 percentage point of growth facing equal quarter of 2014.
In the nine months of the year, adjusted Ebitda rose by 21% to 79.5 million, and the shoreline retreated 0.6 percentage point, to 21.5%.
On 30 September, the net debt of the Ouro Fino was 165.1 million, R$ in 14% lower than in September 30, 2014.